Keywords: Merck & Co, MassBiologics, Tetanus, Diphtheria, Vaccines

Merck & Co gets exclusive US rights to market and distribute MassBiologics' tetanus-diphtheria vaccine

Article | 22 April 2010

Print This

MassBiologics (MBL) of the University of Massachusetts Medical School and US drug major Merck & Co have entered into an ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in